News from generex biotechnology corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 15, 2015, 09:30 ET Generex Announces Memorandum of Understanding in respect of a Phase II Clinical Trial for the Antigen Express Prostate Cancer Vaccine

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that its wholly-owned immunotherapeutics subsidiary, Antigen...


Oct 13, 2015, 09:30 ET Generex Announces Agreement to Acquire Equity Interest in MediTemp Ltd.

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that it has entered into a non-binding Letter of Intent (LOI) with...


Oct 06, 2015, 09:30 ET Generex Announces Agreement to Acquire Equity Interest in Alfa Rhythm Ltd.

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that it has entered into a non-binding Letter of Intent (LOI) with...


Oct 01, 2015, 09:30 ET Generex Announces Issuance of Buccal Cannabis White Paper

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced the issuance of a white paper on the use of cannabis for medicinal...


Sep 30, 2015, 09:30 ET Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that it has entered into a non-binding Letter of Intent (LOI) with...


Sep 08, 2015, 09:30 ET Generex Announces Commencement of Buccal Leuprolide R&D Work

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that research and development work on buccal Leuprolide has begun....


Sep 02, 2015, 09:30 ET Generex Announces Formalization of Buccal Cannabis Co-Development Plan

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that its previously announced intention to implement a buccal...


Aug 27, 2015, 09:30 ET Generex Announces Issuance of Buccal Insulin White Paper

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced the issuance of a white paper on the status of Generex Oral-lyn™,...


Aug 25, 2015, 09:30 ET Generex Provides Update on Success of Buccal Insulin Formulation Enhancement Project

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today provided an update on the status of the buccal insulin formulation...


Jun 24, 2015, 04:01 ET Generex Announces Capital Investment

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that it entered into a securities purchase agreement with an...


May 26, 2015, 09:30 ET Generex Announces Collaboration with NHTherapeutics to Utilize the RapidMist™ Buccal Delivery Technology for Leuprolide

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that it has entered into a Memorandum of Understanding with...


May 14, 2015, 09:30 ET Generex Provides Data Update from AE37 Phase II Breast Cancer Trial One Year Post Completion of Enrollment

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) announced today that updated data from the on-going Phase II clinical trial of the...


May 04, 2015, 09:30 ET Generex Announces Intention to Dividend a Portion of Anticipated SMFI Securities to Its Stockholders upon a Reverse Stock Split

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that it intends to dividend to its stockholders a portion of the...


Apr 23, 2015, 09:45 ET Generex Announces New $11 Million Collaboration on Buccal Cannabis

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that it has entered into a non-binding Letter of Intent (LOI) to...


Apr 21, 2015, 09:30 ET Generex Announces Presentation of Data Correlating Immune Response with Reduction of Relapse in AE37 Phase II Breast Cancer Trial at AACR 2015

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) announced today presentation of data from the on-going Phase II clinical trial of...


Apr 07, 2015, 04:01 ET Generex Acknowledges the Contributions of Its Chairman

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced the resignation of John P. Barratt as a member of the Company's...


Mar 12, 2015, 09:30 ET Generex Provides Update on Buccal Insulin Formulation Enhancement Project

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today provided an update on the status of the buccal insulin formulation...


Feb 17, 2015, 09:30 ET Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that results of the last pre-specified analysis of data from a...


Dec 17, 2014, 09:00 ET Generex Announces Participation in MedCannAccess® - CannScience Partnership on Non-Smoked Forms of Marijuana

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced its participation in a MedCannAccess (www.MedCannAccess.com)...


Nov 18, 2014, 09:30 ET Generex Announces Collaboration on Medicinal Cannabis

Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that it has entered into a non-binding Letter of Intent (LOI) to...


Nov 11, 2014, 09:30 ET Generex Announces Presentation at the Society for Immunotherapy of Cancer Demonstrating that Induction of Antibody Response in Patients Receiving the AE37 Breast Cancer Vaccine Correlates with Reduced Relapse

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced a presentation showing that induction of an antibody response to...


Oct 27, 2014, 09:30 ET Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced two presentations demonstrating that the extent of the...


Oct 23, 2014, 09:30 ET Generex / Antigen Express to Participate in 2014 BIO-Europe® Annual International Partnering Conference

Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that the Company's wholly-owned subsidiary, Antigen Express, Inc....


Oct 21, 2014, 09:30 ET Generex Announces Publication of Ebola Vaccine White Paper by Antigen Express

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that its wholly owned subsidiary, Antigen Express, Inc....


Oct 07, 2014, 09:30 ET Generex Clarifies Utility of Antigen Express Technology for Potential Ebola Vaccine

Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today responded to a recent article posted to the Seeking Alpha website...